Poster Session 1: Late Effects/Quality of Life/Psychosocial Issues

Track: Contributed Abstracts
Wednesday, February 13, 2013: 6:45 PM-7:45 PM
Hall 1 (Salt Palace Convention Center)
196
Outcomes of Patients with Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Mojtaba Akhtari, MD, University of Nebraska Medical Center; Jagar Jasem, MD, University of Nebraska Medical Center; James O Armitage, MD, University of Nebraska Medical Center; Vamshi KS Balasetti, MBBS, University of Nebraska Medical Center; Philip J. Bierman, MD, University of Nebraska Medical Center; Edward A Faber, DO, University of Nebraska Medical Center; Pierre Fayad, MD, University of Nebraska Medical Center (UNMC); Abdul Hadi, MS, University of Nebraska Medical Center; Fausto Rodriguez Loberiza, MD, MS, Univ of Nebraska Med Ctr; Lori Maness, MD, University of Nebraska Medical Center; Armando DA Rosales, University of Nebraska Medical Center; Julie M Vose, MD, University of Nebraska Medical Center; Robert G Bociek, MD, MS, University of Nebraska Medical Center

197
Incidence and Predictors of Late-Occurring Cirrhosis in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT)
Saro H. Armenian, DO, MPH, City of Hope; Canlan Sun, PhD, City of Hope; Emily Blum, City of Hope; Tabitha Vase, City of Hope; Marianne Kang, City of Hope; Lennie Wong, PhD, City of Hope; Stephen J. Forman, MD, City of Hope; Smita Bhatia, MD, MPH, City of Hope

198
Vitamin D Status and Its Correlation with Bone Mineral Density in Long Term Survivors After Childhood Hematopoietic Stem Cell Transplantation
Amy Garee, RN MS PNP, Nationwide Childrens Hospital; Rajinder Bajwa, MBBS, MRCP, MD, Nationwide Children's; Micah Skeens, RN MS PNP, Nationwide Childrens

199
Prevalence of Abdominal Pain Related Functional Gastrointestinal Disorders in Pediatric Recipients of Hematopoietic Stem Cell Transplant
Sonali Chaudhury, MD, Northwestern University Feinberg School of Medicine; Larisa Broglie, MD, Ann & Robert H. Lurie Children's Hospital of Chicago; Karina Danner-Koptik, RN, MSN, APN, Ann & Robert H. Lurie Children's Hospital of Chicago; Kimberly Dilley, Ann & Robert H. Lurie Children's Hospital of Chicago; Morris Kletzel, MD, FAAP, MBA, Northwestern University Feinberg School of Medicine; Miguel Saps, Ann & Robert H. Lurie Children's Hospital of Chicago

200
Outcomes of Lung Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation
Guang-Shing Cheng, MD, University of Washington; David K. Madtes, MD, University of Washington; Jeffrey Edelman, MD, University of Washington; Paul J Martin, MD, Fred Hutchinson Cancer Research Center; Mary E.D. Flowers, MD, Fred Hutchinson Cancer Research Center

201
Gvhd Impact On Quality of Life, Health, Sexuality and Fatigue of LONG TERM Survivors After Hematopoietic STEM CELL Transplant
Maribel Pelaez Doro, Psychologist, Federal University of Parana; Vaneuza Araujo Moreira Funke Sr., MD, MS, Universidade do Parana - UFPR; Jose Zanis Neto, *; Julita M Pelaez, Brazil; Denise Carvalho, Federal University of Parana; Eliane Cezario Maluf Sr., MD, Federal University of Parana; Mariester Malvezzi, MD. MS, Federal University of Parana

202
Allograft Information Exchange (ALLINEX): The Feasibility of Using the Internet for Two Way Information Exchange Between Patients & Tertiary Care - Development & Evaluation
Beverley Horne, St James's Institute of Oncology; Suzanne Liebersbach, BSc Hons., St James's Institute of Oncology; Alex Newsham, St James's Institute of Oncology; Ada Keding, The University of York; Maria H. Gilleece, MD, St James's Institute of Oncology; Penny Wright, St James's Institute of Oncology

203
Fatigue: A Long Standing Symptom Affecting Quality of Life in Patients Following Hematopoietic Cell Transplantation
Therese Hennig, PA-C, Duke University Medical Center; David Rizzieri, M.D., Duke Universtiy Medical Center; Amy Abernathy, M.D., Duke University Medical Center; Tanya Helms, PA-C, Duke University Medical Center; Nelson J. Chao, MD, Duke University Medical Center

204
A Systematic Review and Meta-Analysis of Changes in Cognitive Functioning in Adults Undergoing Hematopoietic CELL Transplantation
Kristin Phillips, PhD, Moffitt Cancer Center; Heather McGinty, University of South Florida; Julie Cessna, University of South Florida; Yasmin Asvat, University of South Florida; Brian Gonzalez, University of South Florida; Mallory Cases, Moffitt Cancer Center; Brent Small, PhD, University of South Florida; Paul Jacobsen, PhD, Moffitt Cancer Center; Joseph Pidala, MD, MS, Moffitt Cancer Center; Heather Jim, PhD, Moffitt Cancer Center

205
Quality of Life Following Allogeneic Hematopoietic CELL Transplant: WHAT Patients Wish They HAD Known
Heather Jim, PhD, Moffitt Cancer Center; Gwendolyn Quinn, Ph.D, Moffitt Cancer Center; Anna Barata-Bardiella, Hospital Sant Pau; Mallory Cases, Moffitt Cancer Center; Julie Cessna, University of South Florida; Juliette Christie, Moffitt Cancer Center; Luis Gonzalez, Moffitt Cancer Center; Clement Gwede, Moffitt Cancer Center; Alexis Koskan, Moffitt Cancer Center; Joseph Pidala, MD, MS, Moffitt Cancer Center

206
The Effect of Exercise Compliance in Patients Undergoing Hematopoietic Stem Cell Transplantation On Their Functional Capacity During Their Hospitalization
Gomati Kanphade, PT, University of Michigan Health System; Paula Rexer, DPT, University of Michigan Health System

207
Supporting Siblings Through the Allogeneic Hematopoietic Cell Transplant Process: The Perspectives of Minor and Young Adult Siblings of Successful Transplant Recipients
Jennifer P. D'Auria, PhD, RN, CPNP, University of North Carolina; Cammie Moore Presler, RN, MSN, CPNP, University of North Carolina; Kimberly A Kasow, DO, University of North Carolina

208
Development of a Pediatric HSCT Multi-Disciplinary Survivor Clinic
Lisa McDonald, DNP, RN, CPNP, Texas Transplant Institute; Julie Luke, DNP, RN, CPNP, Texas Transplant Institute; Taylor Fletcher, Oklahoma State University; Robert Sanders, MD, Texas Transplant Institute; Veronica H Jude, MD, Texas Transplant Institute; Ka Wah Chan, MD, Texas Transplant Institute

209
Osteoporosis/Osteopenia (OP) and Osteonecrosis (ON) in Survivors of Pediatric Stem Cell Transplantation Has a High Assiciation with Graft Versus Host Disease (GVHD)
Joan Morris, MD, Loma Linda University; Christopher Morris, MD PhD, Loma Linda University; Jarrett Riley, DO, Loma Linda University; Brenda Hernandez, RN, Loma Linda University; Rebecca Lee, PharmD, Loma Linda University Medical Center; William Brown, PharmD, Loma Linda University Medical Center

210
Neurocognitive Function in Pediatric Stem Cell Transplant Recipients Following Low Dose Single Fraction Total Body Radiation and Cyclophosphamide
Alexander Ngwube, Washington University in St Louis; Robert Hayashi, MD, St. Louis Children's Hospital; Nicole Cruz, Washington University in St. Louis; Shalini Shenoy, MD, Washington University in St. Louis

211
Adherence to the Outpatient Oral Medication Regime in Adolescent HSCT Recipients
Meghan E McGrady, Ph.D., Cincinnati Children's Hospital Medical Center; Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center; Sarah N Williams, BS, Cincinnati Children's Hospital Medical Center; Ahna LH Pai, Ph.D., University of Cincinnati College of Medicine

212
Ocular Chronic Gvhd: Increasing Opportunities for Impact and Awareness
Ryan Ridges, M.D., Boston Foundation for Sight; Deborah Jacobs, MD, Boston Foundation for Sight; Beth Beard, M.Ed., Boston Foundation for Sight

214
Body Mass Index As an Indicator of Prognosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single Institution Experience
Guillermo Jose Ruiz-Delgado, MD, Clinica Ruiz; Julia A. Lutz-Presno, MD, Clinica Ruiz; Carlos Alarcon-Urdaneta, MD, Clinica Ruiz; Guillermo J. Ruiz-Arguelles, MD, FACP, FRCP(Glasg), Clinica Ruiz

215
Factors Impacting Family Decisions to Pursue Transplantation for Children with Sickle Cell Disease
Amanda L Thompson, PhD, Children's National Medical Center; Eileen Twohy, MA, Children's National Medical Center; Jackie Dioguardi, PA-C, Children's National Medical Center; Emily Riehm Meier, MD, Children's National Medical Center

216
Late Pneumocystis Pneumonia After HSCT: Atypical Presentation and Lack of Correlation with CD4 Count
Taylor Tiffani, PA-C, NCI; Daniele Avila, MSN, NCI; Steven Z. Pavletic, MD, NCI; Daniel Fowler, MD, NCI; Nancy Hardy, MD,, NCI; David Halverson, MD, NCI; Juan Gea-Banacloche, MD, NCI

217
Palliative Care Intergration Into an Acute Leukemia and Bone Marrow Transplant Program
Amy Velasquez, RN BSN OCN, University of Kansas Hospital; Erin Winters, RN, BSN, University of Kansas Hospital

218
Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation
William A Wood, MD, MPH, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; Allison M Deal, MS, Biostatistics Core Facility, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; Amy Abernethy, MD, Division of Medical Oncology, Duke University Medical Center, Duke Cancer Institute; Claudio Battaglini, PhD, Department of Exercise and Sport Science, University of North Carolina at Chapel Hill; Yoon Hie Kim, MPH, Brody School of Medicine, East Carolina University, Greenville, NC; Julia Whitley, BS, University of North Carolina at Chapel Hill; Charlotte Shatten, MA, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; Jonathan S. Serody, MD, University of North Carolina; Thomas C. Shea, MD, University of North Carolina at Chapel Hill; Bryce B Reeve, PhD, Department of Health Policy and Management, Gilllings School of Global Public Health, University of North Carolina at Chapel Hill

219
Symptom Burden in Long-Term Hematopoietic Cell Transplantation (HCT) Survivors
Jean C. Yi, PhD, Fred Hutchinson Cancer Research Center; Barry Storer, PhD, Fred Hutchinson Cancer Research Center; Samantha B. Artherholt, PhD, University of Washington School of Medicine; Eun-Ju Lee, BS, Fred Hutchinson Cancer Research Center; Susan Stewart, Blood & Marrow Transplant Information Network; Mary E.D. Flowers, MD, University of Washington; Karen L Syrjala, PhD, Fred Hutchinson Cancer Research Center

220
Risk Factors for Dry Eye After Hematopoietic Stem Cell Transplantation
Piyada Yotnuengnit, Medicine, Chulalongkorn Hospital; Udomsak Bunworasate, Medicine, Chulalongkorn hospital; Chantiya Chanswangphuwana, Medicine, Chulalonkorn hospital; Vilavun Puangsricharern, Medicine, Chulalongkorn hospital

See more of: Contributed Abstracts